Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 08, 2023

BUY
$39.39 - $51.28 $90,597 - $117,944
2,300 Added 32.86%
9,300 $379,000
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $47,553 - $62,075
-1,139 Reduced 13.99%
7,000 $358,000
Q3 2022

Nov 03, 2022

SELL
$43.76 - $53.42 $72,597 - $88,623
-1,659 Reduced 16.93%
8,139 $356,000
Q2 2022

Aug 08, 2022

SELL
$46.53 - $55.17 $79,566 - $94,340
-1,710 Reduced 14.86%
9,798 $505,000
Q4 2021

Feb 02, 2022

BUY
$41.32 - $61.25 $55,864 - $82,810
1,352 Added 13.31%
11,508 $680,000
Q3 2021

Oct 26, 2021

SELL
$39.25 - $50.42 $23,550 - $30,252
-600 Reduced 5.58%
10,156 $437,000
Q2 2021

Aug 10, 2021

BUY
$35.91 - $40.68 $14,363 - $16,272
400 Added 3.86%
10,756 $421,000
Q1 2021

May 10, 2021

SELL
$33.49 - $37.77 $70,329 - $79,317
-2,100 Reduced 16.86%
10,356 $375,000
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $416,902 - $530,127
12,456 New
12,456 $459,000
Q1 2019

May 08, 2019

SELL
$37.5 - $41.2 $183,937 - $202,086
-4,905 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $7,886 - $8,991
205 Added 4.36%
4,905 $214,000
Q3 2018

Nov 09, 2018

SELL
$34.47 - $41.81 $2.01 Million - $2.44 Million
-58,300 Reduced 92.54%
4,700 $207,000
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $1.41 Million - $1.51 Million
-42,900 Reduced 40.51%
63,000 $2.29 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $3.38 Million - $3.92 Million
105,900 New
105,900 $3.76 Million
Q3 2017

Nov 14, 2017

SELL
$31.0 - $34.15 $511,500 - $563,475
-16,500 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
16,500
16,500 $554,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Sustainable Insight Capital Management, LLC Portfolio

Follow Sustainable Insight Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sustainable Insight Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sustainable Insight Capital Management, LLC with notifications on news.